Form 4: Pratik Shah Transfers ARS Pharmaceuticals Shares to Trusts and Spouse in Recent Transactions

Pratik Shah, a director and 10% owner of ARS Pharmaceuticals, executed several transactions involving the transfer of common stock to trusts and as a gift to his spouse.

Summary

• On June 4, 2024, Pratik Shah transferred 1,332,900 shares of ARS Pharmaceuticals common stock to The Light Irrevocable Trust #1 and 1,332,900 shares to The Star Irrevocable Trust #1.
• These transfers were made in exchange for trust assets of equal value under an asset substitution power.
• Additionally, Pratik Shah gifted 1,332,900 shares of common stock to his spouse on the same date.
• Following these transactions, Pratik Shah directly owns 2,665,800 shares and indirectly owns 7,490,404 shares through The Pratik Shah Living Trust dated June 15, 2011, and 1,332,900 shares through his spouse.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, detailing changes in beneficial ownership. It doesn't inherently convey positive or negative sentiment, but rather reports factual transactions.

Industry Context

This filing reflects insider transactions, which are routinely monitored by investors to gauge management's and major shareholders' sentiment regarding the company's prospects.

Related Party Transactions

• The transfer of shares to The Light Irrevocable Trust #1 and The Star Irrevocable Trust #1, of which Pratik Shah's adult son is a beneficiary, constitutes a related party transaction.
• The gift of shares to Pratik Shah's spouse is also a related party transaction.

Stakeholder Impact

• The transactions may influence investor perception of ARS Pharmaceuticals, depending on how they interpret the insider's actions.
• The transfer of shares to trusts for the benefit of family members could be seen as part of long-term estate planning.

Key Dates